1-15 of 69
Outcomes for PDR Patients LTFU for at Least 1 Year
OphthalmologyOutcomes for PDR Patients LTFU for at Least 1 Year
Examining Therapeutic Timing in RVO-Related Macular Edema
Eye on Ocular HealthExamining Therapeutic Timing in RVO-Related Macular Edema
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
OphthalmologyReal-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Eye on Ocular HealthHow Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Suprachoroidal Steroids in Patients With a History of Glaucoma and Ocular Hypertension
OphthalmologySuprachoroidal Steroids in Patients With a History of Glaucoma and Ocular Hypertension
- advertisement
Anti-VEGF for Proliferative Sickle Cell Retinopathy
Clinical Minute RetinaAnti-VEGF for Proliferative Sickle Cell Retinopathy
Tailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
Eye on Ocular HealthTailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
Mapping the Landscape: Diagnostic Tools in Corneal Health
EmpowerMapping the Landscape: Diagnostic Tools in Corneal Health
- advertisement
From Image to Intervention: Integrating the Diagnosis into Specialty Lens Designs and Corneal Rehabilitation
EmpowerFrom Image to Intervention: Integrating the Diagnosis into Specialty Lens Designs and Corneal Rehabilitation
The Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
Eye on Ocular HealthThe Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
Strategies for Addressing Complications in Retinal Vein Occlusion
Eye on Ocular HealthStrategies for Addressing Complications in Retinal Vein Occlusion
